Status: Recruiting
Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants
The main purpose of this study is to determine the effect of vimseltinib on pharmacokinetics of P-glycoprotein (P-gp) substrate (dabigatran) in healthy male participants. This study will last approximately 21 days.
Participants needed: 20
Trial details
Phase: Phase 1Age: 18-55Biological sex: MaleType: InterventionalSponsor: Deciphera Pharmaceuticals, LLCUpdated: Sep 25, 2026Locations: 1
Eligibility criteria
Participants are in good general health, as required by the protocol and as dete... [+2]
History or presence of clinically significant diseases of the neurological, derm... [+2]